Abstract 4614: Inhibition of NEK2 promotes chemosensitivity and reduces primary effusion lymphoma burden - KIVIRID

Abstract 4614: Inhibition of NEK2 promotes chemosensitivity and reduces primary effusion lymphoma burden

Authors: Maria C. White, Jason P. Wong, Blossom Damania

Published: 2024-03-22

DOI: 10.1158/1538-7445.am2024-4614

Source: Full article

Abstract

Abstract